# Cerebral Embolic Protection Device During TAVR

> **NCT07627984** · NA · COMPLETED · sponsor: **Shanghai Shenqi Medical Technology Co., Ltd** · enrollment: 260 (actual)

## Conditions studied

- Cerebral Embolicprotection Device
- TAVR

## Interventions

- **DEVICE:** Cerebral embolic protection device

## Key facts

- **NCT ID:** NCT07627984
- **Lead sponsor:** Shanghai Shenqi Medical Technology Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-20
- **Primary completion:** 2025-04-16
- **Final completion:** 2025-04-16
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2026-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07627984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07627984, "Cerebral Embolic Protection Device During TAVR". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07627984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*